I still have plenty to say about prostate cancer, its treatment and aftermath. But now I can look at those topics from the point of view of a man leading a post-cancer life.

A fascinating series of pilot programs, including for prostate cancer, has shown that when patients have clinical information about treatments, they often choose a less invasive one.

The treatment of this cancer in its more advanced stages brings about chemical castration by targeting one of several mechanisms involved in the production of testosterone.